Delivery Order HT942523D0019-HT942523F0374
Award Date 9/29/23
Potential Completion Date 9/28/24
Potential Value Not listed
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Denmark
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for operations research and quantitative services delivered by Bavarian Nordic A/S, a biotechnology company focused on cancer immunotherapies and infectious disease vaccines. The $29,216,666 definitive contract was awarded on February 14, 2003 by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, with a completion date of September 30, 2009. The contract does not have a set-aside designation. Bavarian Nordic has provided various...
- This is a Cost Plus Fixed Fee contract awarded by the Defense Threat Reduction Agency (DTRA) to Bavarian Nordic A/S, a biotechnology company based in Denmark. The $510,894.00 contract is for the development of an MVA-BN based Burkholderia vaccine. Bavarian Nordic has a history of collaborating with the U.S. government, including providing endpoint titer analysis services and conducting vaccine research under grants and other contract vehicles. The company holds multiple indefinite delivery...
- This is a federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to IDT Biologika GMBH, a foreign-owned, for-profit biotechnology company based in Germany. The contract is a $70,108.14 delivery order under a larger indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle for manufacturing and characterization services for vaccines and other biologics for infectious diseases. The...
- This is a delivery order under a larger Therapeutics Against Infectious Diseases Phase 1 indefinite delivery/indefinite quantity (IDIQ) contract, awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the U.S. Department of Health and Human Services (HHS). The $117,283 order provides base task funding to the prime contractor, Dynport Vaccine Company LLC, a subsidiary of General Dynamics Corporation, for a Phase 1 clinical trial unit supporting the...
- The U.S. Department of Defense's Medical Supply Chain awarded a $16.5K delivery order to Sr-Services GMBH, a German-based medical technology and procurement company, for BioFire GI Pan 30S diagnostic test kits. This firm fixed price delivery order, awarded on August 1, 2025, with an ultimate completion date of August 8, 2025, will be performed in Germany and carries no set-aside designation. The award reflects Sr-Services GMBH's continued role as a critical medical supplies vendor supporting...
- This is a $24,295,876.00 delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to IDT Biologika GMBH, a German biotechnology company. The contract is for the manufacture of influenza virus human challenge material to support Phase 1 and 2 clinical trials. This work is likely part of NIAID's broader infectious disease research and pandemic preparedness efforts. The contract...
- This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to IDT Biologika GMBH, a German biotechnology company. The contract, valued at $9,317,000.00, is for the manufacturing of master cell banks for next-generation SARS-CoV-2 vaccines as part of pandemic preparedness efforts. The contract is a delivery order with a firm fixed-price pricing structure and has an ultimate completion...
- This is a delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services (HHS), to Dynport Vaccine Company LLC, a subsidiary of General Dynamics Corporation. The $4,120,677 cost-plus-fixed-fee contract is for a Phase 1 clinical trial unit to support the development of therapeutics against infectious diseases. This award is part of the larger Therapeutics Against Infectious Diseases Phase 1 contract vehicle....
- This firm fixed-price purchase order for $89,393.69 was awarded by the Defense Health Agency (DHA) to Becton Dickinson Gesellschaft MIT Beschraenkter Haftung (BD GMBH), a subsidiary of Becton, Dickinson and Company. The contract is for the delivery of microbiological culture media and reagents to support medical facilities and research programs, primarily at the Landstuhl Regional Medical Center in Germany. The contract has a period of performance from October 1, 2023 to September 30, 2024. BD...
- The U.S. Defense Department's Medical Supply Chain organization awarded an $7,991.62 delivery order to Meditrade Medical Trading GMBH, a Germany-based medical supplies contractor, for the provision of hepatitis B surface antigen (HBSAG) test materials. This firm fixed-price delivery order, issued on August 4, 2025, with an ultimate completion date of August 6, 2025, carries no set-aside designation, allowing the vendor to compete in the open federal market. The contract will be performed in...